Variants in the cohesin complex group were a minority (10%, 5/50) because they were analyzed exclusively with panel A, found only in AML patients (14%, 5/37) and mainly affected STAG2 (4/5) (Figure 3). Here, STAG2 is linked to acute myeloid leukemia.